hydrocodone bitartrate


Also found in: Dictionary.

hydrocodone bitartrate

[-kō′dōn]
an opioid antitussive and analgesic.
indications It is prescribed in the treatment of cough and moderate to severe pain.
contraindications Drug dependence or known hypersensitivity to this drug prohibits its use.
adverse effects Among the more serious adverse effects are drug dependence and respiratory and circulatory depression.

hydrocodone bitartrate

(hī″drō-kō′dōn)
A very commonly prescribed opioid pain reliever.
References in periodicals archive ?
The company said the abbreviated new drug application (ANDA) for a Hydrocodone Bitartrate and Chlorpheniramine Maleate Oral Solution 5 mg/4 mg per 5 ml is bioequivalent product to VITUZ Oral Solution.
Pharmaceutical products company Lannett Company Inc (NYSE:LCI) disclosed on Monday the receipt of approval from the US Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrocodone Bitartrate and Acetaminophen Tablets USP in 5 mg/325 mg, 7.
The License Agreement has seen Daravita granting to Zogenix an exclusive license in the United States and its possessions and territories to certain intellectual property rights associated with oral controlled release formulations of hydrocodone bitartrate and allied compounds, including the Company's Zohydro ER product.
is urging the Department of Health & Human Services to overturn the Food and Drug Administration's approval of extended-release hydrocodone bitartrate (Zohydro ER), calling the drug "a powerful and dangerous opioid drug product with a high potential for abuse.
Food & Drug Administration (FDA) for QSC-001, a unique orally disintegrating tablet (ODT) formulation of hydrocodone bitartrate and acetaminophen (HB/APAP) for the treatment of moderate to moderately severe pain.
M2 PHARMA-June 27, 2017-Lannett wins US FDA approval for additional dosage strengths of Hydrocodone Bitartrate and Acetaminophen Tablets USP
M2 EQUITYBITES-June 23, 2017-Lannett wins US FDA approval for Hydrocodone Bitartrate and Acetaminophen Tablets USP in 5 mg/300 mg, 7.
Hydrocodone bitartrate extended-release capsules were approved by the Food and Drug Administration Oct.
West Boylston, charged with larceny over $250, possession of hydrocodone bitartrate, and possession of hydrocodone bitartrate with intent to distribute, released on personal recognizance, continued to April 22.
Food and Drug Administration for the company's Abbreviated New Drug Application ("ANDA") for Hydrocodone Bitartrate and Homatropine Methylbromide Syrup, 5 mg and 1.
M2 PHARMA-June 23, 2017-Lannett wins US FDA approval for Hydrocodone Bitartrate and Acetaminophen Tablets USP in 5 mg/300 mg, 7.